Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Acta Diabetologica
Published in: Acta Diabetologica 2/2019

01-02-2019 | Short Communication

Alternative treatment or alternative to treatment? A systematic review of randomized trials on homeopathic preparations for diabetes and obesity

Authors: Matteo Monami, Antonio Silverii, Edoardo Mannucci

Published in: Acta Diabetologica | Issue 2/2019

Login to get access

Excerpt

Millions of people use homeopathy as an alternative or a complement to “traditional” drugs [1]. Although homeopathic remedies are never included among treatments in International Guidelines, both diabetes and obesity have been proposed as targets of homeopathy [2], and homeopathy is sometimes used for diabetes and its complications [3]. In fact, the use of complementary/alternative medicine (including homeopathy) seems to be common in people with diabetes [4]. …
Literature
1.
Relton C, Cooper K, Viksveen P, Fibert P, Thomas K (2017) Prevalence of homeopathy use by the general population worldwide: a systematic review. Homeopathy 106:69–78CrossRefPubMed
2.
To KLA, Fok YYY, Chong KCM, Lee YCJ, Yiu LSS (2017) Individualized homeopathic treatment in addition to conventional treatment in type II diabetic patients in Hong Kong—a retrospective cohort study. Homeopathy 106:79–86CrossRefPubMedPubMedCentral
3.
Dannemann K, Hecker W, Haberland H, Herbst A, Galler A, Schäfer T, Brähler E, Kiess W, Kapellen TM (2008) Use of complementary and alternative medicine in children with type 1 diabetes mellitus—prevalence, patterns of use, and costs. Pediatr Diabetes 9:228–235CrossRefPubMed
4.
Egede LE, Ye X, Zheng D, Silverstein MD (2002) The prevalence and pattern of complementary and alternative medicine use in individuals with diabetes. Diabetes Care 25(2):324–329CrossRefPubMed
5.
Chakraborti D, Mukherjee SC, Saha KC, Chowdhury UK, Rahman MM, Sengupta MK (2003) Arsenic toxicity from homeopathic treatment. J Toxicol Clin Toxicol 41:963–967CrossRefPubMed
Metadata
Title
Alternative treatment or alternative to treatment? A systematic review of randomized trials on homeopathic preparations for diabetes and obesity
Authors
Matteo Monami
Antonio Silverii
Edoardo Mannucci
Publication date
01-02-2019
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 2/2019
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-018-1235-7

Other articles of this Issue 2/2019

Acta Diabetologica 2/2019 Go to the issue

Original Article

Dietary changes in a diabetes prevention intervention among people with prediabetes: the Diabetes Community Lifestyle Improvement Program trial

Original Article

Duodenal adipose tissue is associated with obesity in baboons (Papio sp): a novel site of ectopic fat deposition in non-human primates

Original Article

Clinical and socio-demographic determinants of inadequate self-care in adults with type 1 diabetes mellitus: the leading role of self-care confidence

Original Article

A 9 years comparison of weight loss, disappearance of obesity, and resolution of diabetes mellitus with biliointestinal bypass and with adjustable gastric banding: experience of a collaborative network

Letter to the Editor

Reply to Gaertner, K. and Frass, M.

Letter to the Editor

Comment on Monami et al. “Alternative treatment or alternative to treatment? A systematic review of randomized trials on homeopathic preparations for diabetes and obesity”

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits